Literature DB >> 18711753

Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.

Wafa' T Al-Jamal1, Khuloud T Al-Jamal, Paul H Bomans, Peter M Frederik, Kostas Kostarelos.   

Abstract

Functionalized-quantum-dot-liposome (f-QD-L) hybrid nanoparticles are engineered by encapsulating poly(ethylene glycol)-coated QD in the internal aqueous phase of different lipid bilayer vesicles. f-QD-L maintain the QD fluorescence characteristics as confirmed by fluorescence spectroscopy, agarose gel electrophoresis, and confocal laser scanning microscopy. Cationic f-QD-L hybrids lead to dramatic improvements in cellular binding and internalization in tumor-cell monolayer cultures. Deeper penetration into three-dimensional multicellular spheroids is obtained for f-QD-L by modifying the lipid bilayer characteristics of the hybrid system. f-QD-L are injected intratumorally into solid tumor models leading to extensive fluorescent staining of tumor cells compared to injections of the f-QD alone. f-QD-L hybrid nanoparticles constitute a versatile tool for very efficient labeling of cells ex vivo and in vivo, particularly when long-term imaging and tracking of cells is sought. Moreover, f-QD-L offer many opportunities for the development of combinatory therapeutic and imaging (theranostic) modalities by incorporating both drug molecules and QD within the different compartments of a single vesicle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711753     DOI: 10.1002/smll.200701043

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  35 in total

Review 1.  Quantum dot-based theranostics.

Authors:  Yi-Ping Ho; Kam W Leong
Journal:  Nanoscale       Date:  2009-10-06       Impact factor: 7.790

Review 2.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

3.  Liposome encapsulation of thiol-capped CdTe quantum dots for enhancing the intracellular delivery.

Authors:  Jun-Yong Wang; Jin-Feng Zhao; Pei-Nan Wang; Wu-Li Yang; Ji-Yao Chen
Journal:  J Fluoresc       Date:  2011-03-16       Impact factor: 2.217

Review 4.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

5.  Uptake and intracellular fate of multifunctional nanoparticles: a comparison between lipoplexes and polyplexes via quantum dot mediated Förster resonance energy transfer.

Authors:  Yun Wu; Yi-Ping Ho; Yicheng Mao; Xinmei Wang; Bo Yu; Kam W Leong; L James Lee
Journal:  Mol Pharm       Date:  2011-07-19       Impact factor: 4.939

6.  Quantiosomes as a multimodal nanocarrier for integrating bioimaging and Carboplatin delivery.

Authors:  Chwan-Fwu Lin; Chih-Jen Wen; Ibrahim A Aljuffali; Chun-Lin Huang; Jia-You Fang
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

Review 7.  Biosafe nanoscale pharmaceutical adjuvant materials.

Authors:  Shubin Jin; Shengliang Li; Chongxi Wang; Juan Liu; Xiaolong Yang; Paul C Wang; Xin Zhang; Xing-Jie Liang
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

8.  A Low-Cost Nanomaterial-based Electrochemical Immunosensor on Paper for High-Sensitivity Early Detection of Pancreatic Cancer.

Authors:  K Sudhakara Prasad; Xiyue Cao; Ning Gao; Qijie Jin; Sharma T Sanjay; Gilberto Henao-Pabon; XiuJun Li
Journal:  Sens Actuators B Chem       Date:  2019-12-02       Impact factor: 7.460

9.  Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.

Authors:  Hyung-Jun Im; Christopher G England; Liangzhu Feng; Stephen A Graves; Reinier Hernandez; Robert J Nickles; Zhuang Liu; Dong Soo Lee; Steve Y Cho; Weibo Cai
Journal:  ACS Appl Mater Interfaces       Date:  2016-07-07       Impact factor: 9.229

Review 10.  Quantum dots as a platform for nanoparticle drug delivery vehicle design.

Authors:  Christine E Probst; Pavel Zrazhevskiy; Vaishali Bagalkot; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2012-09-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.